Oxidized or Native Low-Density Lipoprotein Cholesterol * Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Which Is More Important in Atherogenesis?*

Journal of the American College of Cardiology

Volumn 48, Issue 5, 2006, Pages 980-982

  Mehta, Jawahar L ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EDITORIAL; GENDER; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; PRIORITY JOURNAL; SMOKING;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 33747883300     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.06.001     Document Type: Editorial

References (30)

1. Fox C.S., Evans J.C., Larson M.G., Kannel W.B., and Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999. the Framingham Heart Study. Circulation 110 (2004) 522-527
2. Ridker P.M., Brown N.J., Vaughan D.E., Harrison D.G., and Mehta J.L. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109 Suppl 1 (2004) IV6-IV19
3. Lee K.W., Blann A.D., and Lip G.Y. Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes. Thromb Haemost 94 (2005) 1077-1083
4. Morrow D.A., and Ridker P.M. C-reactive protein-a prognostic marker of inflammation in atherothrombosis. In: Mehta J.L. (Ed). Inflammatory and Infectious Basis of Atherosclerosis (2001), Birkhauser, Verlag, Basel, Switzerland 203-220
5. Smith Jr. S.C., Anderson J.L., Cannon III R.O., et al. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the clinical practice discussion group. Circulation 110 (2004) e550-e553
6. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
7. Blankenberg S., Tiret L., Bickel C., et al., AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106 (2002) 24-30
8. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease. implications for risk assessment. J Am Coll Cardiol 44 (2004) 1945-1956
9. Mehta J.L., and Li D.Y. Inflammation in ischemic heart disease. response to tissue injury or a pathogenetic villain?. Cardiovasc Res 43 (1999) 291-299
10. McEwen J.E., Zimniak P., Mehta J.L., and Reis R.J. Molecular pathology of aging and its implications for senescent coronary atherosclerosis. Curr Opin Cardiol 20 (2005) 399-406
11. Das S., Ray R., Snehlata, Das N., and Srivastava L.M. Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis. Mol Cell Biochem 285 (2006) 143-147
12. Chen L., Haught W.H., Yang B., Saldeen T.G., Parathasarathy S., and Mehta J.L. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 30 (1997) 569-575
13. Leborgne L., Pakala R., Dilcher C., et al. Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbits. J Cardiovasc Pharmacol 46 (2005) 540-547
14. Melov S., Ravenscroft J., Malik S., et al. Extension of life-span with superoxide dismutase/catalase mimetics. Science 289 (2000) 1567-1569
15. Knekt P., Ritz J., Pereira M.A., et al. Antioxidant vitamins and coronary heart disease risk. a pooled analysis of 9 cohorts. Am J Clin Nutr 80 (2004) 1508-1520
16. Li D., Yang B., and Mehta J.L. Ox-LDL induces apoptosis in human coronary artery endothelial cells. role of PKC, PTK, bel-2, and Fas. Am J Physiol 275 (1998) H568-H576
17. Mehta J.L., Li D.Y., Chen H.J., Joseph J., and Romeo F. Inhibition of LOX-1 by statins may relate to upregulation of eNOS. Biochem Biophys Res Comm 289 (2001) 857-861
18. Absood A., Furutani A., Kawamura T., and Graham L.M. Differential PDGF secretion by graft and aortic SMC in response to oxidized LDL. Am J Physiol Heart Circ Physiol 283 (2002) H725-H732
19. Inoue M., Itoh H., Tanaka T., et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol 21 (2001) 560-566
20. Chen L.Y., Mehta P., and Mehta J.L. Oxidized-LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets. relevance in the effect of oxidized-LDL on platelet function. Circulation 93 (1996) 1740-1746
21. Li D., Liu L., Chen H.F., et al. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23 (2003) 816-821
22. Li D.Y., Zhang Y.C., Philips M.I., Sawamura T., and Mehta J.L. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type I receptor activation. Circ Res 84 (1999) 1043-1049
23. Li D., Singh R.M., Liu L., et al. Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells. Cardiovasc Res 57 (2003) 238-243
24. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1930-1932
25. Nordin Fredrikson G., Hedblad B., Berglund G., and Nilsson J. Plasma oxidized LDL. a predictor for acute myocardial infarction?. J Intern Med 253 (2003) 425-429
26. Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 844-888
27. Holvoet P., Harris T.B., Tracy R.P., et al. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly. findings from the Health, Aging, and Body Composition Study. Arterioscler Thromb Vasc Biol 23 (2003) 1444-1448
28. Hayashida K., Kume N., Murase T., et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome. a novel marker for early diagnosis. Circulation 112 (2005) 812-818
29. Wu T., Willett W.C., Rifai N., Shai I., Manson J.E., and Rimm E.B. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?. J Am Coll Cardiol 48 (2006) 973-979
30. Yusuf S., Hawken S., Ounpuu S., et al., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). case-control study. Lancet 364 (2004) 937-952